Nine months ahead of the delivery of The Hive, its first asset in France, Kadans Science Partner, a subsidiary of Axa Im Alts, has signed three new leases with Paris Saclay Cancer Cluster, Sanofi and Orakl Oncology.
Nine months ahead of the delivery of The Hive, its first asset in France, Kadans Science Partner, a subsidiary of Axa Im Alts, has signed three new leases with Paris Saclay Cancer Cluster, Sanofi and Orakl Oncology.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In